Medscape: How primary care doctors can contribute to epilepsy care
The Centers for Disease Control and Prevention (CDC) estimates that while 89% of patients with epilepsy reported seeing a physician in the past year about their condition, only 62% saw a neurologist or seizure specialist.
With demand for neurologists projected to exceed supply in 41 states by 2025, primary care providers are well-positioned to help fill the gap and assist in the management of patients with seizure disorders.
In an article about primary care physicians' expanding role in epilepsy management, Medscape highlighted Project ECHO, a training program piloted at the University of Cincinnati designed to train primary care providers in epilepsy management.
Through Zoom, experts like Michael Privitera, MD, professor and division chief for epilepsy in UC's College of Medicine, train primary care providers across the country through monthly hour-long Zoom sessions.
According to research Privitera and colleagues published in Epilepsy & Behavior, 98% of participants reported greater interest and comfort in epilepsy treatment after participating in the pilot portion of the training from 2017-2019.
Featured photo at top of Michael Privitera, MD, speaking with a patient. Photo courtesy of UC Health.
Related Stories
UC marks 4 years saving lives with mobile stroke unit
August 15, 2024
The University of Cincinnati's Christopher Richards spoke with Local 12 about the four-year anniversary of the mobile stroke unit that can bring the emergency department directly to patients.
Trial finds new drug safe, effective to treat deadliest form of epilepsy
October 23, 2024
MSN highlighted research presented by the University of Cincinnati’s Brandon Foreman that found ganaxolone is a safe and effective treatment for refractory status epilepticus.
Jacksonville media: New stroke research aims to help predict recovery
April 18, 2023
Jacksonville, Florida television news station WJXT highlighted the VERIFY study being led by University of Cincinnati researchers that will examine if certain biomarkers can predict the likelihood that a patient will recover motor functions following a stroke.